Alvotech
SE0025011463 Short position disclosed on June 22, 2026.
2.50% of the capital sold short
4 disclosing funds
9 disclosures on record
Funds holding Alvotech Titelia
Evolution of the disclosed total
0%1%2%3%
2025-13-01Mar 2026May 2026Jul 2026
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Linden Advisors LP | 0.73% | new | June 22, 2026 | |
| Whitebox Advisors LLC | 0.63% | new | December 18, 2025 | |
| Acasta Partners UK LLP | 0.57% | unchanged | June 17, 2026 | |
| Harriet Lance Jones | 0.57% | new | June 17, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 30, 2026 | Acasta Partners UK LLP | 0.49% | June 30, 2026 |
| June 22, 2026 | Linden Advisors LP | 0.73% | still open |
| June 17, 2026 | Acasta Partners UK LLP | 0.57% | still open |
| June 17, 2026 | Harriet Lance Jones | 0.57% | still open |
| June 10, 2026 | Harriet Lance Jones | 0.61% | still open |
| June 9, 2026 | Acasta Partners UK LLP | 0.61% | still open |
| January 7, 2026 | Linden Advisors LP | 0.95% | still open |
| December 18, 2025 | Whitebox Advisors LLC | 0.63% | still open |
| December 17, 2025 | Acasta Partners UK LLP | 0.57% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
- Elekta AB (publ) 10.32% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.83% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Stillfront Group AB (publ) 3.87% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- RaySearch Laboratories AB (publ) 3.63% of the capital sold short